Specifically, in hepatocellular carcinoma (HCC) patients, increased ACE2 expression reflects a longer survival time compared to those with decreased ACE2 expression, which implies the prognosis role of ACE2 in HCC.21 This evidence concerns the gene ACE2 and hepatocellular carcinoma.